Announcements Trials
Browse Landscape

Phase

Phase 4 19Phase NA 17Phase 2 12Phase 3 11Phase 1/2 2Phase 2/3 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Gastrointestinal 1Breast 1

Conditions

Anemia, Refractory, with Excess of Blasts 32Leukemia, Myeloid, Acute 31Myelodysplastic Syndromes 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Leukemia 21Leukemia, Myelomonocytic, Chronic 18Lymphoma, Non-Hodgkin 17Myeloproliferative Disorders 15Thrombocytopenia 13Anemia, Aplastic 13Anemia 12Hodgkin Disease 11Hematologic Neoplasms 11Multiple Myeloma 10Lymphoma 10Leukemia, Lymphocytic, Chronic, B-Cell 9Anemia, Refractory 9Lymphoma, Mantle-Cell 8Lymphoma, Follicular 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Fanconi Anemia 7Congenital Abnormalities 7Blast Crisis 7Leukemia, Myeloid, Chronic-Phase 6Leukemia, Myeloid, Accelerated Phase 6Cytopenia 6Neoplasms 5Lymphoma, B-Cell, Marginal Zone 5Burkitt Lymphoma 5Primary Immunodeficiency Diseases 4

Interventions

Sodium Chloride 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Febrile Neutropenia × Classical hematology × Clear all
NCT03104595 2023-08-15

Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer

Enzychem Lifesciences Corporation

Phase 1/2 Completed
28 enrolled
BreastClassical hematology

Breast Neoplasms, Febrile Neutropenia

NCT01619423 2018-07-06

PLIANT

Egetis Therapeutics

Phase 1/2 Completed
186 enrolled 12 charts
Classical hematologyGastrointestinal

Neutropenia, Colorectal Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡